| NDC Code | 31722-739-05 |
|---|
| Package Description | 500 TABLET, FILM COATED in 1 BOTTLE (31722-739-05) |
|---|
| Product NDC | 31722-739 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Lamivudine And Zidovudine |
|---|
| Non-Proprietary Name | Lamivudine And Zidovudine |
|---|
| Dosage Form | TABLET, FILM COATED |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20140206 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA203259 |
|---|
| Manufacturer | Camber Pharmaceuticals, Inc. |
|---|
| Substance Name | LAMIVUDINE; ZIDOVUDINE |
|---|
| Strength | 150; 300 |
|---|
| Strength Unit | mg/1; mg/1 |
|---|
| Pharmacy Classes | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA] |
|---|